Comment on ‘Sustained Discontinuation of Infliximab With a Raising-Dose Strategy After Obtaining Remission in Patients With Rheumatoid Arthritis: The RRRR Study, a Randomised Controlled Trial’ by Tanaka Et Al

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2019-216557
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Adalimumab Discontinuation in Patients With Rheumatoid Arthritis After Achieving Sustained Remission

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2018English

Does Intensive Management Improve Remission Rates in Patients With Intermediate Rheumatoid Arthritis? (The TITRATE Trial): Study Protocol for a Randomised Controlled Trial

Trials
MedicinePharmacology
2017English

Spontaneous Remission of Marginal Zone B Cell Lymphoma in a Patient With Seropositive Rheumatoid Arthritis After Discontinuation of Infliximab-Methotrexate Treatment

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients With IBD After Discontinuation of One-Year Infliximab Therapy

PLoS ONE
Multidisciplinary
2014English

A Randomised Controlled Trial of Occupational Therapy for People With Early Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2004English

Aggressive Treatment in Early Rheumatoid Arthritis: A Randomised Controlled Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2000English

Correction: Discontinuation of Adalimumab After Achieving Remission in Patients With Established Rheumatoid Arthritis: 1-Year Outcome of the HONOR Study: Table 3

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2016English

Targeting Ultrasound Remission in Early Rheumatoid Arthritis: The Results of the TaSER Study, a Randomised Clinical Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2016English

Discontinuation of Adalimumab After Attaining Disease Activity Score 28-Erythrocyte Sedimentation Rate Remission in Patients With Rheumatoid Arthritis (HONOR Study): An Observational Study

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy